Trial reportGlobal health research and policy2025
Economic evaluation of financial incentives for maternal and child health in the Democratic Republic of the Congo (DRC): a decision-tree modelling based on a cluster randomized controlled trial.
Trial report in Global health research and policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo improve the utilization of maternal and child health (MCH) services, the Democratic Republic of the Congo initiated a performance-based financing (PBF) program in 2017. An impact evaluation of the PBF program was conducted in 2023 using a cluster randomized controlled trial research design. This study aimed to assess the cost-effectiveness of the PBF program in comparison with the direct facility financing (DFF) program.
methodsA decision-tree model incorporating key MCH services was developed to estimate cost-effectiveness. Data on costs of maternal health services, epidemiological consequences, and utilities of various health statuses were obtained from the literature. The impact evaluation results on the coverage of key MCH services were included as key inputs to simulate the effectiveness measured as quality-adjusted life years (QALYs). Sensitivity analyses were conducted on the inclusion of the PBF's impact on the quality of care and the uncertainty regarding the costs and the impact of PBF on MCH services.
resultsA total of US$205.9 million in 2021 dollar was spent on the PBF arm over the five years (2017-2021), with 70.60% allocated as incentive payments to health facilities and 19.41% as financial transfers to provincial purchasing agencies for contracting PBF facilities and managing the PBF program. On average, the annual cost per capita was estimated at US$2.05 and US$1.71 for implementing the PBF and DFF program, respectively. Without the quality adjustment, the improvement in MCH services resulted in 1,372 lives (192,036 QALYs) saved over 2017-2021. The incremental cost-effectiveness ratio (ICER) of the PBF program reached US$ 1,374 per QALY with substantial variation. After adjusting for quality, the ICER of PBF became smaller.
conclusionsUsing three times the gross domestic product per capita in 2021 (US$1,732) as the threshold, the PBF program is a cost-effective strategy, though with substantial variation. It is crucial to take action to maintain gains from the improved MCH coverage resulting from the PBF program.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.